Predicting Response to Neoadjuvant Endocrine Therapy (Neo-PREDICT)

Clinical trial NCT06806930 · RECRUITING

Trial details

NCT number: NCT06806930
Sponsor: George Washington University
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Breast Cancer Stage I Breast Cancer Stage II Breast Cancer Stage III Carcinoma, Breast

Start date: 2024-10-01
Primary completion: 2028-10-01
Enrollment: 90

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.